Ixekizumab Plus Tirzepatide Improves Psoriatic Arthritis Outcomes Over Monotherapy
• Combination therapy of ixekizumab and tirzepatide yields better results in psoriatic arthritis patients compared to ixekizumab alone, per recent medical research. • This finding advances treatment options for the chronic inflammatory condition affecting joints and skin. • Updated clinical approaches could enhance patient quality of life and disease management.
Read original · medicalxpress.com

